Evolus to Report Second Quarter 2020 Financial Results and Provide a Business Update on Monday, August 10, 2020
July 27 2020 - 3:01PM
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a
customer-centric approach focused on delivering breakthrough
products, announced today that it will report its second quarter
2020 financial results and provide a business update on Monday,
August 10, 2020 after the close of the U.S. financial markets.
Management will host a conference call and live webcast to
discuss Evolus’ financial results at 4:30 p.m. ET that same day. A
question and answer session will follow management remarks.
The dial-in numbers for the conference call are (866) 916-2317
for domestic callers and (703) 925-2662 for international
callers. The conference ID is 7575816.
A replay of the call will be available following its completion
through August 17, 2020. To access the replay, dial (855) 859-2056
for domestic callers and (404) 537-3406 for international callers
and use the replay conference ID 7575816.
A live audio webcast of the call will be available on the
Investor Relations page of the Evolus, Inc. website,
https://investors.evolus.com. A replay of the webcast will be
archived on Evolus' website for 30 days following the completion of
the call.
About Evolus, Inc.Evolus is a performance
beauty company with a customer-centric approach focused on
delivering breakthrough products. In 2019, the U.S. Food and
Drug Administration approved Jeuveau®
(prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated
exclusively to aesthetics and manufactured in a state-of-the-art
facility using Hi-Pure™ technology. Jeuveau® is powered
by Evolus' unique technology platform and is designed to
transform the aesthetic market by eliminating the friction points
existing for customers today. Visit us
at: http://www.evolus.com.
Jeuveau® is a registered trademark of Evolus, Inc.Hi-Pure™ is a
trademark of Daewoong Pharmaceutical Co, Ltd.
Evolus, Inc. Contacts:
Investor Contact:Ashwin AgarwalVice President, Finance, Investor
Relations & TreasuryTel: +1-949-284-4559Email:
IR@Evolus.com
Media Contact:Crystal MuilenburgVice President, Corporate
Communications & Public RelationsTel: +1-949-284-4506Email:
media@evolus.com
Evolus (NASDAQ:EOLS)
Historical Stock Chart
From Apr 2024 to May 2024
Evolus (NASDAQ:EOLS)
Historical Stock Chart
From May 2023 to May 2024